Fresh analysis reveals that patients who discontinue blockbuster weight-loss injections like semaglutide or tirzepatide may regain shed pounds far faster than those who end traditional diet and exercise plans.
Published data in a prominent medical journal shows that while overweight individuals frequently drop substantial amounts of their body weight while using the jabs, the mass is regained at an average rate of 0.8 kg per month after stopping.
"Users purchasing these treatments must be aware of the potential of quick rebound weight gain when the medication ends," warns researcher Dr. Susan Jebb.
This pace of regain means a return to starting weight within about 18 months.
Weighing Therapies
The study, which looked at dozens of trials involving over 9,000 of participants, contrasted the outcomes of these new drugs with older methods.
Researchers note that individuals who shed pounds through dieting typically see a slower creep back—perhaps 0.1 kg a month—after stopping.
Explaining the Rapid Regain
Experts believe the way of the injections is key to understanding the heightened weight return.
These medications mimic a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.
"Sustained high doses of GLP-1 concentrations several times higher than normal could lead to the body to generate a reduced amount of its own natural GLP-1, and may also lessen responsiveness to its effects," noted Dr. Adam Collins, a dietetics researcher.
"Withdrawal of this medication leads to appetite is uncontrolled, making excessive eating a significant risk."
A Lifelong Condition?
Health authorities recommend the jabs for people with weight-linked health risks, accompanied by recommended lifestyle changes.
A number of clinicians contend that, given the significant potential of relapse, the therapy should be considered life-long.
This opinion is echoed by pharmaceutical companies, who note that the findings "highlight the chronic character of excess weight," similar to managing diseases like diabetes.
User Experiences
Users who have come off the medication explain a powerful resurgence of cravings.
"It felt as if a trigger activating and you become ravenous," said one woman.
This difficulty is compounded if patients have not established lasting lifestyle or habit modifications during treatment.
Widespread Interest
Figures show that a significant number of adults in the UK have used weight-loss jabs in the past year, with desire being substantial.
- Adoption is higher among females compared to men.
- The middle-aged age group shows the greatest level of interest.
- Many obtain the drugs through private healthcare rather than public health services.
Ultimately, clinicians caution that while GLP-1 drugs are powerful agents for weight loss, they are not a permanent cure and maintained weight loss hinges on ongoing lifestyle support.
